Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients.
Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Radiant is a biotechnology company developing the next generation of multi-specificity.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.
Harpe Bio develops sustainable weed control solutions for organic and industrial agriculture.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Dispatch Biotherapeutics develops immunotherapy that treats solid tumors, which could significantly advance cancer treatment options.
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..
Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
Marvin is made to empower caregivers, leading the global transformation to a modern and sustainable healthcare system.
Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.
MOMA Therapeutics operates as a biotechnology company.
Alexandria Venture Investments has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 22 different industry categories.
Among tracked funding rounds, Dispatch Bio received $216.0M in a Series A round. Alexandria Venture Investments's total known invested capital is $6.2B.
Alexandria Venture Investments's average investment size is $44.4M across its portfolio of 186 companies.
Recent Alexandria Venture Investments portfolio additions include Alphina Therapeutics, Thryv Therapeutics, Novome Biotechnologies, Codiak Biosciences, Radiant Biotherapeutics. These companies were founded in 2020 or later.